161 related articles for article (PubMed ID: 3466644)
1. Surface marker analysis in acute myeloid leukaemia and correlation with FAB classification.
San Miguel JF; Gonzalez M; Cañizo MC; Anta JP; Zola H; Lopez Borrasca A
Br J Haematol; 1986 Nov; 64(3):547-60. PubMed ID: 3466644
[TBL] [Abstract][Full Text] [Related]
2. TdT activity in acute myeloid leukemias defined by monoclonal antibodies.
San Miguel JF; González M; Cañizo MC; Anta JP; Portero JA; López-Borrasca A
Am J Hematol; 1986 Sep; 23(1):9-17. PubMed ID: 3461712
[TBL] [Abstract][Full Text] [Related]
3. Correlation of surface marker expression with morphologically and immunologically defined subclasses of acute myeloid leukaemias.
Drexler HG; Menon M; Klein M; Bhoopalam N; Messmore HL; Minowada J
Clin Exp Immunol; 1986 Aug; 65(2):363-72. PubMed ID: 3466728
[TBL] [Abstract][Full Text] [Related]
4. Antigenic phenotype of the myeloid leukaemic cells defined by monoclonal antibodies.
Robak T; Korycka A
Arch Immunol Ther Exp (Warsz); 1987; 35(1):33-42. PubMed ID: 3477133
[TBL] [Abstract][Full Text] [Related]
5. Immune phenotype heterogeneity in AML.
Ost A; Christensson B; Andreasen R; Hast R; Lagerlöf B; Reizenstein P; Trowbridge IS; Biberfeld P
Scand J Haematol; 1985 Apr; 34(4):293-302. PubMed ID: 3159074
[TBL] [Abstract][Full Text] [Related]
6. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia.
Pombo de Oliveira MS; Matutes E; Rani S; Morilla R; Catovsky D
Acta Haematol; 1988; 80(2):61-4. PubMed ID: 2901804
[TBL] [Abstract][Full Text] [Related]
7. Staging of leukemic progenitor cells in acute myeloid leukemia by phenotyping with myeloid monoclonal antibodies.
Hast R; Dowding C; Robak T; Goldman JM
Exp Hematol; 1986 Nov; 14(10):981-7. PubMed ID: 3464449
[TBL] [Abstract][Full Text] [Related]
8. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
[TBL] [Abstract][Full Text] [Related]
9. Discrepancies between morphologic, cytochemical, and immunologic characteristics in acute myeloblastic leukemia.
del Canizo MC; San Miguel JF; Gonzalez M; Anta JP; Orfao A; Lopez-Borrasca A
Am J Clin Pathol; 1987 Jul; 88(1):38-42. PubMed ID: 3474879
[TBL] [Abstract][Full Text] [Related]
10. Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis.
Drexler HG; Menon M; Gaedicke G; Minowada J
Cancer Immunol Immunother; 1986; 21(3):188-92. PubMed ID: 3457629
[TBL] [Abstract][Full Text] [Related]
11. Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia.
Griffin JD; Davis R; Nelson DA; Davey FR; Mayer RJ; Schiffer C; McIntyre OR; Bloomfield CD
Blood; 1986 Dec; 68(6):1232-41. PubMed ID: 2946331
[TBL] [Abstract][Full Text] [Related]
12. Expression of monocytic and T-lymphocytic phenotype in a variant form of acute promyelocytic leukaemia (M3).
Sato T; Abe R; Kawaguchi M; Uchida T; Kariyone S
Scand J Haematol; 1986 Aug; 37(2):151-3. PubMed ID: 3489982
[TBL] [Abstract][Full Text] [Related]
13. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
Urbano-Ispizua A; Matutes E; Villamor N; Sierra J; Pujades A; Reverter JC; Feliu E; Cervantes F; Vives-Corrons JL; Montserrat E
Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689
[TBL] [Abstract][Full Text] [Related]
14. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
15. The use of monoclonal antibodies for the identification and classification of acute myeloid leukemias.
Drexler HG; Minowada J
Leuk Res; 1986; 10(3):279-90. PubMed ID: 3512924
[TBL] [Abstract][Full Text] [Related]
16. Correlation of morphological FAB classification and immunophenotyping: value in recognition of morphological, cytochemical and immunological characteristics of mixed leukaemias.
Boban D; Sucić M; Marković-Glamocak M; Uzarević B; Batinić D; Marusić M; Nemet D; Labar B; Hitrec V
Eur J Cancer; 1993; 29A(8):1167-72. PubMed ID: 8518029
[TBL] [Abstract][Full Text] [Related]
17. Classifying acute leukemia by immunophenotyping: a combined FAB-immunologic classification of AML.
Neame PB; Soamboonsrup P; Browman GP; Meyer RM; Benger A; Wilson WE; Walker IR; Saeed N; McBride JA
Blood; 1986 Dec; 68(6):1355-62. PubMed ID: 3465377
[TBL] [Abstract][Full Text] [Related]
18. Immunological markers in acute leukaemia.
Avnstrøm S; Ralfkier E; Clausen N; Plesner T; Hansen NE; Nissen NI
Scand J Haematol; 1985 Jan; 34(1):16-21. PubMed ID: 3918339
[TBL] [Abstract][Full Text] [Related]
19. Variable differentiation of human acute myeloid leukaemia during colony formation in vitro: a membrane marker analysis with monoclonal antibodies.
Touw I; Löwenberg B
Br J Haematol; 1985 Jan; 59(1):37-44. PubMed ID: 3882131
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotype of clonogenic cells in myeloid leukaemia.
Kabral A; Bradstock KF; Grimsley P; Favaloro EJ
Leuk Res; 1988; 12(1):51-9. PubMed ID: 3162752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
